TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35585483

Group type: EXPERIMENTAL
Intervention: Intravenous dexmedetomidine (DEX)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 60
Study: 33793960

Group type: EXPERIMENTAL
Intervention: Continuous EEG (cEEG)
Number of subjects: 366

Group type: COMPARATOR
Intervention: Routine EEG (rEEG)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: cEEG
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Duration of acute hospitalisation
Number of subjects: 366
Study: 33130217

Group type: EXPERIMENTAL
Intervention: pm‐Pac (230 mg/m2) plus cisplatin (70 mg/m2)
Number of subjects: 448

Group type: COMPARATOR
Intervention: sb‐Pac (175 mg/m2) plus cisplatin (70 mg/m2)
Number of subjects: 448
Study: 32652516

Group type: EXPERIMENTAL
Intervention: PCR diet (30% calorie and 80% protein reduction)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (without restrictions)
Number of subjects: 35
Study: 33844408

Group type: EXPERIMENTAL
Intervention: Low FODMAP dietary advice
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard dietary advice
Number of subjects: 59
Study: 32234584

Group type: EXPERIMENTAL
Intervention: Protect Your Family intervention
Number of subjects: 1475

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 1475
Study: 34761392

Group type: EXPERIMENTAL
Intervention: Self-assessment using the study roadmap tool
Number of subjects: 30

Group type: COMPARATOR
Intervention: Instructor supervision only (Control)
Number of subjects: 30
Study: 32024402

Group type: EXPERIMENTAL
Intervention: Percutaneous microwave ablation (PMWA)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Ultrasound-guided radiofrequency ablation (USgRFA)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: PMWA
Number of subjects: 133

Group type: COMPARATOR
Intervention: USgRFA
Number of subjects: 133
Study: 34501248

Group type: EXPERIMENTAL
Intervention: sCXL (standard Dresden protocol) with 30 min pre-soaking and 3 mW/cm2 UVA irradiation for 30 min
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: aCFXL (accelerated custom-fast protocol) with 10 min pre-soaking and 1.8 ± 0.9 mW/cm2 UVA irradiation for 10 min ± 1.5 min
Number of subjects: 41

Group type: COMPARATOR
Intervention: Comparison between sCXL and aCFXL
Number of subjects: 41
Study: 36037146

Group type: EXPERIMENTAL
Intervention: Short-term drainage (drain removed 24 hours after surgery)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Long-term drainage (drain removed 5 days after surgery)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Short-term drainage
Number of subjects: 88
Study: 35585525

Group type: EXPERIMENTAL
Intervention: PRISM intervention (resilience-coaching program with four scripted coaching sessions targeting skills in stress-management, goal setting, cognitive-restructuring, and meaning-making)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 90
Study: 34663421

Group type: EXPERIMENTAL
Intervention: Cervical vertebral mobilization technique and exercise
Number of subjects: 28

Group type: COMPARATOR
Intervention: Minimal superficial circular pressure on the skin and exercise
Number of subjects: 28
Study: 32624365

Group type: EXPERIMENTAL
Intervention: self-locking stand-alone cage
Number of subjects: 120

Group type: COMPARATOR
Intervention: plate group
Number of subjects: 120
Study: 35063352

Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) model based on transfer learning using chest radiographs (CRs)
Number of subjects: 3972
Study: 34919414

Group type: EXPERIMENTAL
Intervention: Animal-assisted interactions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 35766028

Group type: EXPERIMENTAL
Intervention: Tafamidis
Number of subjects: 78
Study: 33043978

Group type: EXPERIMENTAL
Intervention: Voluntary Medical Male Circumcision (VMMC)
Number of subjects: 3916

Group type: COMPARATOR
Intervention: Uncircumcised men (Control)
Number of subjects: 3916
Study: 35633401

Group type: EXPERIMENTAL
Intervention: High power (HP) laser lithotripsy settings
Number of subjects: 120

Group type: COMPARATOR
Intervention: Low power (LP) laser lithotripsy settings
Number of subjects: 120
Study: 34636753

Group type: EXPERIMENTAL
Intervention: Ropivacaine with dexmedetomidine (group RD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ropivacaine with normal saline (group R)
Number of subjects: 60
Study: 35388496

Group type: EXPERIMENTAL
Intervention: Metacognitive training (MCT)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 46
Study: 34678981

Group type: EXPERIMENTAL
Intervention: Sevelamer (2400 mg daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Calcium carbonate (1500 mg daily)
Number of subjects: 40
Study: 32821251

Group type: EXPERIMENTAL
Intervention: Recollection-based occupational therapy program (24 sessions, 5 times per week for 1 hour each)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular activities offered by existing facilities (Control group)
Number of subjects: 0
Study: 34487834

Group type: EXPERIMENTAL
Intervention: Participants in the exercise RCT
Number of subjects: 914

Group type: COMPARATOR
Intervention: Non-participants and non-invited women
Number of subjects: 914
Study: 34981234

Group type: EXPERIMENTAL
Intervention: Blocked training schedule
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Random training schedule
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no additional training)
Number of subjects: 44
Study: 34131002

Group type: EXPERIMENTAL
Intervention: Prexasertib at 70 mg/m2 i.v. with olaparib at 100 mg by mouth twice daily
Number of subjects: 29

Group type: COMPARATOR
Intervention: Olaparib alone (7-day lead-in)
Number of subjects: 29
Study: 32437393

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT) using commercially‐available anaerobic cultivated human intestinal microbiota (ACHIM)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 36322184

Group type: EXPERIMENTAL
Intervention: High BAC (0.08%)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Low BAC (0.05%)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 33621007

Group type: EXPERIMENTAL
Intervention: Monopolar TUR (M-TURBT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Bipolar TUR (B-TURBT)
Number of subjects: 80
Study: 35927705

Group type: EXPERIMENTAL
Intervention: Virtual cognitive-behavioral sexual counseling (8 sessions of 90 minutes)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine prenatal care
Number of subjects: 80
Study: 32763538

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS), 20 treatments over four weeks
Number of subjects: 153
Study: 35671327

Group type: EXPERIMENTAL
Intervention: SOC+RT (Standard of Care plus Radiotherapy)
Number of subjects: 1939

Group type: COMPARATOR
Intervention: SOC (Standard of Care)
Number of subjects: 1939
Study: 33199796

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) for 15 weeks
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control (sedentary)
Number of subjects: 55
Study: 36459264

Group type: EXPERIMENTAL
Intervention: CHARISMA intervention to increase women's agency to use oral pre‐exposure prophylaxis (PrEP) safely and consistently.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CHARISMA intervention
Number of subjects: 0
Study: 33892086

Group type: EXPERIMENTAL
Intervention: Effective Dose 50 (ED50) method for depression
Number of subjects: 1122

Group type: EXPERIMENTAL
Intervention: PHQ‐9
Number of subjects: 1122

Group type: EXPERIMENTAL
Intervention: GAD‐7
Number of subjects: 1122
Study: 32410485

Group type: EXPERIMENTAL
Intervention: Caffeine intake (baseline)
Number of subjects: 9694
Study: 35609409

Group type: EXPERIMENTAL
Intervention: Standard pemetrexed maintenance therapy
Number of subjects: 365

Group type: COMPARATOR
Intervention: Durvalumab
Number of subjects: 365
Study: 35018526

Group type: EXPERIMENTAL
Intervention: Spiritually sensitive logotherapy intervention (twelve-session group programme)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (secular control interventions)
Number of subjects: 60
Study: 33760859

Group type: EXPERIMENTAL
Intervention: VR training with augmented multisensory cues
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Conventional VR training
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group (real tyre change only)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: All VR training paradigms
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Augmented multisensory cues
Number of subjects: 3
Study: 32715995

Group type: EXPERIMENTAL
Intervention: TAVI
Number of subjects: 1660

Group type: EXPERIMENTAL
Intervention: SAVR
Number of subjects: 1660
Study: 34991472

Group type: EXPERIMENTAL
Intervention: Digital Photo-Activity
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control activity
Number of subjects: 90
Study: 34006055

Group type: EXPERIMENTAL
Intervention: 3% Hypertonic saline (HS) solution
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lactated Ringer's (LR) solution
Number of subjects: 40
Study: 34953787

Group type: EXPERIMENTAL
Intervention: N2O
Number of subjects: 60

Group type: COMPARATOR
Intervention: Argon
Number of subjects: 60
Study: 36212187

Group type: EXPERIMENTAL
Intervention: Apalutamide plus ADT
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Apalutamide
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: ADT
Number of subjects: 90

Group type: COMPARATOR
Intervention: Overall population
Number of subjects: 90

Group type: COMPARATOR
Intervention: Apalutamide plus ADT, Apalutamide, ADT
Number of subjects: 90
Study: 32198561

Group type: EXPERIMENTAL
Intervention: 17-item stigma measure
Number of subjects: 1263
Study: 35334570

Group type: EXPERIMENTAL
Intervention: L-alanyl L-glutamine dipeptide
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 33831213

Group type: EXPERIMENTAL
Intervention: Exenatide (2 mg, subcutaneously, once-weekly)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT, 21 mg)
Number of subjects: 84
Study: 35804410

Group type: EXPERIMENTAL
Intervention: Processing speed training interventions with varying attentional control demands (choice reaction time, switching, dual tasks)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Active control group training simple reaction time tasks with minimal attentional control demands
Number of subjects: 400
Study: 34841427

Group type: EXPERIMENTAL
Intervention: Internet quiz game intervention
Number of subjects: 4294

Group type: COMPARATOR
Intervention: Conventional health education
Number of subjects: 4294
Study: 35354662

Group type: EXPERIMENTAL
Intervention: Comprehensive quality improvement intervention 'STEP' (Strategies, Toolkit, Exploration, Paradigm)
Number of subjects: 7644

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 7644
Study: 34311697

Group type: EXPERIMENTAL
Intervention: Clinician support package comprising face‐to‐face sessions, group discussion, simulated consultations, patient vignettes, and model consultation videos
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Support from senior clinicians
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monitoring of GP performance and provision of regular feedback
Number of subjects: 0
Study: 34916380

Group type: EXPERIMENTAL
Intervention: TJ-107
Number of subjects: 0
Study: 34867725

Group type: EXPERIMENTAL
Intervention: Continuous Prism Adaptation (PA-c)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intermittent Prism Adaptation (PA-i)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Passive treatment (historical control)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo treatment (historical control)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Prism Adaptation treatment with fewer therapy sessions (historical control)
Number of subjects: 24
Study: 34758057

Group type: COMPARATOR
Intervention: High flow: 70 l · min‐1, continuous jaw thrust
Number of subjects: 125

Group type: COMPARATOR
Intervention: Medium flow: 10 l · min‐1, continuous jaw thrust
Number of subjects: 125

Group type: COMPARATOR
Intervention: Low flow: 2 l · min‐1, continuous jaw thrust
Number of subjects: 125

Group type: COMPARATOR
Intervention: Minimal flow: 0.25 l · min‐1, endotracheal tube
Number of subjects: 125
Study: 33784688

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Electroacupuncture + Tropisetron
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Tropisetron
Number of subjects: 264

Group type: COMPARATOR
Intervention: Control
Number of subjects: 264
Study: 35938348

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy for insomnia (CBT‐I)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 112
Study: 34362525

Group type: EXPERIMENTAL
Intervention: Non ABO‐HDN patients
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Non ABO‐HDN direct antibody test
Number of subjects: 67
Study: 33932000

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with moxibustion (seed-sized moxa cone)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fluoxetine hydrochloride capsule 20 mg once a day
Number of subjects: 60
Study: 35603590

Group type: EXPERIMENTAL
Intervention: Fibre supplementation (wheat bran, pectin, green banana flour)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Fibre/water (2 l/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fibre
Number of subjects: 20
Study: 32065967

Group type: EXPERIMENTAL
Intervention: Chlorhexidine bathing
Number of subjects: 312

Group type: COMPARATOR
Intervention: Soap-and-water bathing
Number of subjects: 312
Study: 36401501

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG) supplementation during the first 6 months of life
Number of subjects: 184

Group type: COMPARATOR
Intervention: Control group (no LGG supplementation)
Number of subjects: 184
Study: 33616613

Group type: EXPERIMENTAL
Intervention: Telephone Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 327

Group type: COMPARATOR
Intervention: Education-only control (EOC)
Number of subjects: 327
Study: 32876697

Group type: EXPERIMENTAL
Intervention: Fixed-dose hydrocortisone (50 mg or 100 mg every 6 hours)
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Shock-dependent hydrocortisone (50 mg every 6 hours when shock was clinically evident)
Number of subjects: 384

Group type: COMPARATOR
Intervention: No hydrocortisone
Number of subjects: 384
Study: 36009980

Group type: EXPERIMENTAL
Intervention: Colistin combined with sulbactam at 12 g/day
Number of subjects: 88

Group type: COMPARATOR
Intervention: Colistin combined with sulbactam at 9 g/day
Number of subjects: 88
Study: 32617651

Group type: EXPERIMENTAL
Intervention: Subchondral cell therapy (20 mL of bone marrow concentrate with 5727 MSCs/mL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intra-articular cell therapy (20 mL of bone marrow concentrate with 5727 MSCs/mL)
Number of subjects: 60
Study: 35330416

Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control (Saline)
Number of subjects: 102
Study: 32202692

Group type: EXPERIMENTAL
Intervention: Oxytocin (64 IU total, 40 IU followed by 24 IU after 80 minutes)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (administered in the same dosing schedule as oxytocin)
Number of subjects: 52
Study: 35631293

Group type: EXPERIMENTAL
Intervention: CBD (30 mg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: CBD (30 mg) with food
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 33931829

Group type: EXPERIMENTAL
Intervention: Peloid therapy + home exercise program
Number of subjects: 106

Group type: COMPARATOR
Intervention: Home exercise program
Number of subjects: 106
Study: 33428148

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance with nerve stimulation (group U-N)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Nerve stimulation alone (group N)
Number of subjects: 44
Study: 35000098

Group type: EXPERIMENTAL
Intervention: Single-dose paltusotine 1.25 to 20 mg
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Multiple-dose paltusotine 5 to 30 mg administered once daily for 10 days
Number of subjects: 41
Study: 34189636

Group type: EXPERIMENTAL
Intervention: Trabectedin 1.1 mg/m2 plus pegylated liposomal doxorubicin (PLD) 30 mg/m2, administered intravenously every 21 days until disease progression or unacceptable toxicity.
Number of subjects: 18
Study: 32075887

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD) tailored to habitual energy intakes (MedD)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Regular diets (ConD)
Number of subjects: 82
Study: 35398981

Group type: EXPERIMENTAL
Intervention: First-Person Perspective Action Observation training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Third-Person Perspective Action Observation training
Number of subjects: 20
Study: 33325768

Group type: EXPERIMENTAL
Intervention: Scared-straight flipcharts with salient information about disease severity and cash incentives
Number of subjects: 1660

Group type: COMPARATOR
Intervention: Control flipcharts with written explanation about the severity of the disease
Number of subjects: 1660
Study: 34001178

Group type: EXPERIMENTAL
Intervention: Mobile phone application (MPA)
Number of subjects: 0
Study: 32062765

Group type: EXPERIMENTAL
Intervention: Family Check-Up (FCU) intervention
Number of subjects: 709
Study: 34376082

Group type: EXPERIMENTAL
Intervention: Vignette-based studies assessing victim blaming
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Causal attribution statement for rape or theft
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Social reactions reported by interpersonal trauma survivors
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Interpersonal trauma responses
Number of subjects: 3
Study: 33026537

Group type: EXPERIMENTAL
Intervention: Micro-fragmented adipose tissue injection
Number of subjects: 20
Study: 35289500

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil/amlodipine besylate tablet (20 mg/5 mg) under fasting conditions
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil/amlodipine besylate tablet (20 mg/5 mg) under fed conditions
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (fed condition)
Number of subjects: 56
Study: 32165403

Group type: EXPERIMENTAL
Intervention: FENO guided treatment (not treated with LTRA)
Number of subjects: 1112

Group type: EXPERIMENTAL
Intervention: FENO guided treatment (non-obese children)
Number of subjects: 1112
Study: 35652746

Group type: EXPERIMENTAL
Intervention: Centanafadine 200 mg/d
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Centanafadine 400 mg/d
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study: 33528901

Group type: EXPERIMENTAL
Intervention: Individualised mixed management intervention (4 sessions of face-to-face lactation education and psychoeducation)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Individualised mixed management intervention
Number of subjects: 182
Study: 32730283

Group type: EXPERIMENTAL
Intervention: Glidescope® Go™
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Dahlhausen VL
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: King Vision™
Number of subjects: 112

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Glidescope® Go™ and Dahlhausen VL
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: I-View™
Number of subjects: 112
Study: 36272502

Group type: EXPERIMENTAL
Intervention: DON group (10 mg DON/kg of feed)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (mycotoxin-free diet)
Number of subjects: 24
Study: 35831789

Group type: EXPERIMENTAL
Intervention: Exercise-Intensive program
Number of subjects: 70

Group type: COMPARATOR
Intervention: Light-load exercise program
Number of subjects: 70
Study: 34297944

Group type: EXPERIMENTAL
Intervention: AI-assisted endoscopy (AI-first group)
Number of subjects: 1812

Group type: COMPARATOR
Intervention: Routine white light endoscopy (routine-first group)
Number of subjects: 1812
Study: 33238245

Group type: EXPERIMENTAL
Intervention: Kinesio tape application
Number of subjects: 19

Group type: COMPARATOR
Intervention: Non-Kinesio tape (control)
Number of subjects: 19
Study: 36199287

Group type: EXPERIMENTAL
Intervention: Increasing load while keeping repetitions constant (LOAD)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Increasing repetitions while keeping load constant (REPS)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Both LOAD and REPS
Number of subjects: 43
Study: 34408409

Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training (HIIT, n = 33)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Moderate Intensity Continuous Training (MICT, n = 24)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (n = 48) following national physical activity guidelines
Number of subjects: 105
Study: 32762663

Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC) at a fixed dose of 2.7 g/day (900 mg three times daily) for 12 weeks
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC)
Number of subjects: 126
Study: 36321334

Group type: EXPERIMENTAL
Intervention: VSD combined with flap transplantation and immunosuppressive agent treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal dressing change combined with hormone and cyclosporine
Number of subjects: 30
Study: 33763794

Group type: EXPERIMENTAL
Intervention: Pilocarpine administration
Number of subjects: 91

Group type: COMPARATOR
Intervention: Laser peripheral iridotomy (LPI)
Number of subjects: 91
Study: 34133828

Group type: EXPERIMENTAL
Intervention: C. butyricum + 1,25(OH)2 D3 (CD)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: C. butyricum (Cb)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: C. butyricum (Cb) and C. butyricum + 1,25(OH)2 D3 (CD)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control (Con)
Number of subjects: 360
Study: 33039671

Group type: EXPERIMENTAL
Intervention: Initial care for early fasting hyperglycaemia (n = 255)
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: Initial care for early fasting hyperglycaemia (n = 137, FPG ≥ 5.5 mmol/L)
Number of subjects: 523